Edition:
United States

Stratec Biomedical AG (SBSG.DE)

SBSG.DE on Xetra

65.76EUR
15 Dec 2017
Change (% chg)

€-0.93 (-1.39%)
Prev Close
€66.69
Open
€66.70
Day's High
€66.70
Day's Low
€65.43
Volume
10,849
Avg. Vol
11,842
52-wk High
€70.33
52-wk Low
€44.52

Chart for

About

Stratec Biomedical AG (Stratec) is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of clinical diagnostics and biotechnology. It is primarily active in the in vitro diagnostics industry and focuses on the segment... (more)

Overall

Beta: 0.20
Market Cap(Mil.): €783.92
Shares Outstanding(Mil.): 11.92
Dividend: 0.77
Yield (%): 1.17

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-Stratec Biomedical 9mth adj EBIT up at EUR 24.0 mln

* ‍ADJUSTED EBIT MARGIN OF 15.9% IN 9M|2017 (9M|2016: 14.6%)​

Oct 26 2017

BRIEF-STRATEC Biomedical H1 net profit down 3.5 percent at 9.9 mln euros

* NOT ISSUING ANY SPECIFIC STATEMENT CONCERNING ITS EXPECTATIONS FOR 2018

Jul 25 2017

Earnings vs. Estimates